Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.
Tribalto, M
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study. [electronic resource] - Haematologica Jan 2000 - 52-8 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0390-6078
Adult
Age Factors
Antigens, CD34--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Blood Component Removal
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Dexamethasone--administration & dosage
Disease-Free Survival
Erythrocyte Transfusion
Evaluation Studies as Topic
Follow-Up Studies
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematopoietic Stem Cell Transplantation
Humans
Infections--etiology
Italy
Male
Middle Aged
Multiple Myeloma--complications
Myeloablative Agonists--therapeutic use
Neutrophils
Platelet Count
Prognosis
Retrospective Studies
Risk Factors
Stem Cells
Survival Rate
Transplantation, Autologous
Treatment Outcome
Vincristine--administration & dosage
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study. [electronic resource] - Haematologica Jan 2000 - 52-8 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0390-6078
Adult
Age Factors
Antigens, CD34--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Blood Component Removal
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Dexamethasone--administration & dosage
Disease-Free Survival
Erythrocyte Transfusion
Evaluation Studies as Topic
Follow-Up Studies
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematopoietic Stem Cell Transplantation
Humans
Infections--etiology
Italy
Male
Middle Aged
Multiple Myeloma--complications
Myeloablative Agonists--therapeutic use
Neutrophils
Platelet Count
Prognosis
Retrospective Studies
Risk Factors
Stem Cells
Survival Rate
Transplantation, Autologous
Treatment Outcome
Vincristine--administration & dosage